Viral Vaccines I 5/17/04 LECTURE OUTLINE I. CASE HISTORY
|
|
- Christiana Oliver
- 5 years ago
- Views:
Transcription
1 Viral Vaccines I I. CASE HISTORY LECTURE OUTLINE 5/17/04 A 22-year-old Amish woman became ill with a headache, fever, and generalized muscle pain. Two days later, she developed right and then left lower extremity weakness and decreased deep tendon weakness. She had been to 3 weddings of Amish couples within the past 2 months and these Amish populations were positive for the virus in question. II. DISEASE: POLIO A. CHARACTERISTICS: A local GI tract infection that may develop into a systemic illness with severity ranging from inapparent to a nonparalytic febrile illness, to an aseptic meningitis, to paralytic disease and possibly death (due to respiratory failure). Symptoms include: fever, malaise, headache, nausea, vomiting, neck or back stiffness with or without paralysis. Virus replicates in GI tract and viremia may then follow with CNS invasion resulting in lower extremity flaccid paralysis. Inapparent infections are >100-fold times more common than the paralytic cases. 4-8 % of those exposed contract a minor illness (gastroenteritis or flu-like symptoms). 1-2% get aseptic meningitis. and 0.1-1% become paralytic. Fatality rate for paralytic cases is 2-10%. B. AGENT: Poliovirus types 1, 2, 3. C. HOST & HIGH RISK POPULATIONS Host: Human High risk population: Worldwide, developed countries have a higher risk of serious infections due to lack of exposure in infancy. Characteristically, a disease of children and adolescents in endemic countries. In developed countries, disease is seen in adults. Population not getting vaccines. Outbreaks in preschool children (not yet immunized) or members of religious groups who do not believe in immunization. D. VECTOR & TRANSMISSION: Vector: Humans Transmission: Fecal/oral route in areas of poor sanitation. Usually direct contact (pharyngeal spread) through close association. Rarely, milk and contaminated foodstuff. Flies. E. INCIDENCE , 115,800 cases/year; 1955 and 1963 vaccines introduced. Post Average of cases/year; 1987 [0], 1992 [4], 1993 [0], 1997 [3], 1998[1], 1999[0], 2001[0] F. IMMUNITY AFTER ACTIVE DISEASE Usually type-specific immunity life-long, even from inapparent infections. III. IV. TREATMENT: None VACCINE A. TYPE OF VACCINE: Inactivacted virus. IPOL (Aventis Pasteur). $15.42/dose 1
2 B. SCHEDULE AND ROUTE OF ADMINISTRATION Route: Subcutaneous or intramuscular Schedule: 2, 4, 6-18 months and 4-6 years. C. EFFICACY AND DURATION OF IMMUNITY ~100% D. COMPLICATIONS Swelling < 5% Fever (w/i 48 hr) < 5% E. CONTRAINDICATIONS Previous anaphylactic reaction to IPV Anaphylactic reaction to neomycin, polymyxin B, or streptomycin Severe acute illness 2
3 LECTURE OUTLINE I. CASE HISTORY A 16-year-old Snohomish County man developed fever, bronchitis and Koplik spots on his buccal mucosa while visiting England. One week after his return, his 19-year-old sister developed a rash. Other persons developing the illness were: a 16-year-old friend of the sister, two people sharing the plane flight of the index case, and a 13-month-old contact of one of the plane cases. All had fever >101, generalized rash, cough and conjunctivitis. II. DISEASE: MEASLES. aka: Hard measles, Rubeola, 10 day measles." A. CHARACTERISTICS: Prodromal fever, conjunctivitis, Koplik spots, barking cough, and a blotchy rash. First on the forehead, then to head, then abdomen. Complications of disease include: Otitis media (7%) Diarrhea (8%) Pneumonia (6%) Encephalitis (0.1%), fatality 15%! Residual neurological damage in 25% of survivors. B. AGENT: Measles virus. Genus Morbillivus in the Paramyxovirus family. C. HOST & HIGH RISK POPULATIONS Host: Humans High risk populations: In unvaccinated population, 90% of the children will get measles by the time they are 20 years old. In vaccinated population, outbreaks are sometimes observed in schools and colleges. D. VECTOR & TRANSMISSION Vector: Humans Transmission: Airborne (droplet) - rare. Direct contact of nasal/throat secretions. **Highly contagious, high secondary attack rate. E. INCIDENCE Recent number of cases (USA cumulative): 1986 (6273), 1987 (3579), (56,000 cases), 1993 (312), 1996 (508), 1997 (138), 1998(100), 1999(86), 2001(108) F. IMMUNITY AFTER ACTIVE DISEASE: Lifelong 3
4 III. TREATMENT: None for infected cases. For contacts: Human pooled immunoglobulin (IgG). Passive. The titers are not particularly high. Given <72 hours after exposure. Given to contacts of high risk population (<1-year-old) or who the vaccine is contraindicated: immunosuppressed or pregnant. After IgG administration you need to wait 5-12 months to give the vaccine. IV. VACCINE A. TYPE OF VACCINE: Live attenuated virus. Attenuvax (Merck). A component of MMR. Often produces a mild illness. $10.40/dose for just attenuvax. $28.19 for MMR Refrigerate, don t freeze vaccine. Once it is reconstituted it must be used w/i 8 hrs or throw it out. Note: Killed vaccine given in gave inadequate protection. Recipients should be re-vaccinated. B. SCHEDULE AND ROUTE OF ADMINISTRATION Route: Subcutaneous Schedule: months (earlier the immune system is too immature) and 4-6 years. Any dose given <12 months of age does not count. C. EFFICACY AND DURATION OF IMMUNITY 80-95% Effective in eliciting humoral and cellular immunity 10-20% vaccine failures (2-3,000 cases/yr) [CDC says 2-5% of recipients don t respond] D. COMPLICATIONS Vaccine-related measles 5-15 days after administration (5-15% fever, 5% rash) Diffuse retinopathy and optic problems Neurologic (within 1 month of vaccine) <1/M doses Simple febrile seizures rare. F. CONTRAINDICATIONS Previous anaphylactic reaction to MMR, gelatin or neomycin Pregnancy at time or within 3 months No blood products within 3-11 months Immunocompromised (except asymptomatic HIV) Active, untreated TB Severe illness (postpone giving vaccine) 4
5 LECTURE OUTLINE I. CASE HISTORY An 11 year old boy develops a mild fever, testicular tenderness and swelling and pain around the jaw. He lived. II. DISEASE: MUMPS A. CHARACTERISTICS: Acute viral disease with fever, swelling and tenderness in one or more salivary glands, usually the parotid. Orchitis occurs in 15-25% of males, but does not result in sterility. CNS is often involved (aseptic meningitis, 50-60% of cases, symptomatic meningitis is observed in up to 15% of the cases). Rarely (deafness). B. AGENT: Mumps virus. Paramyxovirus genus. C. HOST & HIGH RISK POPULATIONS Host: Humans. Childhood disease---highest incidence 5-14 years old. One-third have inapparent illness % have just respiratory symptoms. Prodromal symptoms nonspecific, e.g. low-grade fever, headache and respiratory irritation. D. VECTOR & TRANSMISSION Vector: Humans Transmission: Droplet spread. Direct contact with saliva. E. INCIDENCE Recent number of cases (USA cumulative): 212,000 before the vaccine, 1986 [5,411], 1987 [12,259], 1993 [1,692], 1996 [751], 1997 [683], 1998[666], 1999[352], 2001[231] F. IMMUNITY AFTER ACTIVE DISEASE: Life-long. III. IV. TREATMENT: None. Post-exposure prophylaxis is not effective. VACCINE A. TYPE OF VACCINE: Live attenuated vaccine. Introduced in Mumpsvax (Merck). $13.36/dose B. SCHEDULE AND ROUTE OF ADMINISTRATION Route: Subcutaneous Schedule: months, 4-6 years. C. EFFICACY AND DURATION OF IMMUNITY 97% of the children and 93% of the susceptible adults develop immunity. Duration: Persists at least 10 years. Presumably life-long. D. COMPLICATIONS Occasional mild fever. Rarely, febrile seizures. This is one of the safest live viral vaccines available. 5
6 G. CONTRAINDICATIONS Previous anaphylactic reaction to MMR, gelatin or neomycin Pregnancy at time or within 3 months No blood products within 3-11 months Immunocompromised (except asymptomatic HIV) Active, untreated TB Severe illness (postpone giving vaccine) 6
7 LECTURE OUTLINE I. CASE HISTORY A pregnant women developed a mild fever and a diffuse macular rash during her first trimester. She recovered completely without seeking medical care. Her baby was born at term with congenital defects ranging from cataracts to cardiac problems to mental retardation. II. DISEASE: Rubella (aka "German measles" and 3-day measles). A. CHARACTERISTICS: Milder form of measles. Prodromal period of headache, low fever, and malaise - lasting 1-5 days. Also, symptoms of upper respiratory infection. Diffuse macular rash in 50-80% of the cases. Muscle pain and arthritis (especially in adult females). Infection during first trimester - wide variety congenital defects (20-25%). Encephalitis (rarely). Arthritis frequently observed with adults (~70% of women) % subclinical infections. B. AGENT: Rubella virus. C. HOST & HIGH RISK POPULATIONS: Humans. High risk Population: Children and adolescents. Outbreaks occur in pre-vaccinated population every 6-9 years. Now outbreaks in: institutions, military and colleges. D. VECTOR & TRANSMISSION Transmission: Airborne (droplet). Direct contact with nasopharyngeal secretions. Indirectcontaminated fomites. Highly contagious. E. INCIDENCE USA secular trends: 1964 before vaccine: 0.5 million cases; 30,000 still births; 20,000 congenital defects. Recent number of cases (USA cumulative): 1986 [ CRS], 1987 [328], 1992 [160], 1993 [192], 1996 [238], 1997 [181 5 CRS], 1998 [364-7 CRS], 1999 [238_8 CRS], 2001[19_2 CRS] All outbreaks since 1996 have been in foreign-born individual. All CRS cases since 1996 have occurred in kids of unvaccinated women born in Latin America. F. IMMUNITY AFTER ACTIVE DISEASE: Lifelong. III. TREATMENT IgG given if infection is in pregnancy (does not prevent infection, but does suppress symptoms). In general, however, post-exposure prophylaxis is ineffective. IV. VACCINE A. TYPE OF VACCINE: Live attenuated virus. Meruvax II (Merck), licensed $11.46/dose 7
8 B. SCHEDULE AND ROUTE OF ADMINISTRATION Route: Subcutaneous Schedule: months and 4-6 years. Give as MMR, women of childbearing age should get it if they have not been vaccinated (must not be pregnant!!). C. EFFICACY AND DURATION OF IMMUNITY Efficacy: 95% Duration: Presumably life-long. High levels of protective antibodies have been observed in people vaccinated in D. COMPLICATIONS Fever and rash. Local: Swelling <48 hrs. Estimated theoretical risk of serious congenital malformations (3%); but none observed. FAR LESS THAN RISK FROM NATURAL INFECTION (20%) Arthritis: Up to 40% of the people who are vaccinated have simple joint pain. Frank arthritis in only 2% of the cases, but 10-15% if female. Persists only 2 weeks and then disappears. E. CONTRAINDICATIONS Previous anaphylactic reaction to MMR, gelatin or neomycin Pregnancy at time or within 3 months No blood products within 3-11 months Immunocompromised (except asymptomatic HIV) Active, untreated TB Severe illness (postpone giving vaccine) Vaccine given to unknowingly pregnant women. From , 1,176 (CDC 321) women were given the vaccine during their first trimester and none of the offspring had congenital defects, but the women got the rubella infection at the rate of 1%. 8
Measles, Mumps and Rubella. Ch 10, 11 & 12
Measles, Mumps and Rubella Ch 10, 11 & 12 Measles Highly contagious viral illness First described in 7th century Near universal infection of childhood in prevaccination era Remains the leading cause of
More informationMEASLES, MUMPS, RUBELLA (MMR)
MEASLES, MUMPS, RUBELLA (MMR) WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST MEASLES, MUMPS OR RUBELLA? GET INFORMED! GET VACCINATED! GET PROTECTED! MMR VACCINE
More informationMeasles and Measles Vaccine
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition
More informationMeasles Update. March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief
Measles Update March 16, 2015 Lisa Miller, MD, MSPH Communicable Disease Branch Chief Lynn Trefren MSN, RN Immunization Branch Chief Colorado Department of Public Health and Environment Presenters have
More informationLECTURE OUTLINE. B. AGENT: Varicella-zoster virus. Human herpes virus 3. DNA virus.
Viral Vaccines II LECTURE OUTLINE 5/24/04 I. CASE HISTORY A 5-year old comes home from school with a red skin rash on his chest that spreads to over 300 itchy blisters that spread further to his face,
More informationUpdate on Mumps and Current Status of Outbreak in NW Arkansas
Update on Mumps and Current Status of Outbreak in NW Arkansas Dirk Haselow, MD, PhD State Epidemiologist Medical Director for Outbreak Response Arkansas Department of Health 1 Vaccines have been proven
More informationDISCLOSURES. I have no actual or potential conflicts of interest in this presentation.
OVERVIEW ON MEASLES Oneka B. Marriott, DO, MPH, FAAP, FACOP Assistant Professor of Pediatrics and Public Health Nova Southeastern University College of Osteopathic Medicine Presentation to FSACOFP Annual
More informationDESCRIPTION OF MUMPS
New Jersey Dept. of Health and Senior Services Vaccine Preventable Disease Program Mumps Public FAQs Date: February 16, 2010 Time: 12:00 PM DESCRIPTION OF MUMPS What is mumps? Mumps is caused by a virus.
More informationVaccine Preventable Diseases. Overview MEASLES 4/8/2015. Amy Schwartz, MPH Immunization Surveillance Coordinator North Dakota Department of Health
Vaccine Preventable Diseases Amy Schwartz, MPH Immunization Surveillance Coordinator North Dakota Department of Health Measles Mumps Pertussis Meningococcal Disease Polio Rubella Hepatitis A Overview MEASLES
More informationHelp protect your child. At-a-glance guide to childhood vaccines.
Help protect your child. At-a-glance guide to childhood vaccines. Why vaccines matter. Thanks to widespread vaccination programs, several diseases that can infect our children have been eliminated. But
More informationHelp protect your child. At-a-glance guide to childhood vaccines.
Help protect your child. At-a-glance guide to childhood vaccines. Why vaccines matter. Thanks to widespread vaccination programs, several diseases that can infect our children have been eliminated. But
More informationMeasles 2015: What We Need to Know
Faculty Measles 2015: What We Need to Know Karen Landers, MD, FAAP Assistant State Health Officer Tuberculosis Control and Immunization Alabama Department of Public Health Produced by the Alabama Department
More informationHelp protect your child. At-a-glance guide to childhood vaccines.
Help protect your child. At-a-glance guide to childhood vaccines. 40976_CDCupdate.indd 1 Why vaccines matter. Thanks to widespread vaccination programs, several diseases that can infect our children have
More informationDiphtheria. Vaccine Preventable Childhood Diseases. General information
Diphtheria General information Caused by the bacterium Corynebacterium diphtheria. Transmission is most often person-to-person spread via respiratorydroplets. The word diphtheria comes from Greek and means
More informationThe Ministry of Health recommends measles vaccines for all child care providers, children and parents to ensure they are protected against measles.
Since January 1, 2014, there have been several cases of measles reported in Saskatchewan. Because measles is a highly contagious vaccine-preventable disease and there are a number of unvaccinated children
More information9/11/2018. Measles. Measles, Mumps, and Rubella. Measles Complications. Paramyxovirus Nasopharynx is primary site of infection
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Measles, Mumps, and Rubella September 2018 Chapters 13, 15 and 20 Photographs and images included in
More informationMEASLES, MUMPS, RUBELLA (MMR)
MEASLES, MUMPS, RUBELLA (MMR) WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST MEASLES, MUMPS OR RUBELLA? GET INFORMED! GET VACCINATED! GET PROTECTED! MMR VACCINE
More informationEXANTHEMATOUS ILLNESS. IAP UG Teaching slides
EXANTHEMATOUS ILLNESS 1 DEFINITIONS Exanthema eruption of the skin Exanthema eruption of mucosae Macule flat nonpalpable lesion Papule small palpable lesion Nodule large palpable lesion Vesicle small fluid
More informationMumps. October Susan Even MD University of Missouri-Columbia. Robert Palinkas MD University of Illinois at Urbana-Champaign
Mumps October 20 2014 Susan Even MD University of Missouri-Columbia Robert Palinkas MD University of Illinois at Urbana-Champaign Craig Roberts PA-C, MS University of Wisconsin-Madison Objectives Define
More informationMEASLES HEALTH ALERT/ADVISORY. Date: February 5, Dear Colleague:
MEASLES HEALTH ALERT/ADVISORY Date: February 5, 2019 Dear Colleague: Details of situation: Five measles cases, four between the ages of 12 to 21 months, have been reported in three different counties within
More informationCounty of Santa Cruz. General Questions About Measles HEALTH SERVICES AGENCY. Public Health Division. What is measles?
County of Santa Cruz Public Health Division HEALTH SERVICES AGENCY POST OFFICE BOX 962, 1080 EMELINE AVE., SANTA CRUZ, CA 95060 TELEPHONE: (831) 454-4000 FAX: (831) 454-4770 General Questions About Measles
More informationPARAMYXOVIRUS FAMILY properties of attachment protein
PARAMYXOVIRUS FAMILY properties of attachment protein GENUS GLYCOPROTEINS TYPICAL MEMBERS Paramyxovirus genus Rubulavirus Genus HN, F HN, F HPIV1, HPIV3 HPIV2, HPIV4 mumps virus Morbillivirus genus Pneumovirus
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Mumps Public Frequently Asked Questions. Date: September 9, 2013
New Jersey Department of Health Vaccine Preventable Disease Program Mumps Public Frequently Asked Questions Date: September 9, 2013 DESCRIPTION OF MUMPS What is mumps? Mumps is a contagious disease that
More informationMeasles: United States, January 1 through June 10, 2011
Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA
More informationMEASLES. Tracey Johnson Infection Control Specialist Nurse
MEASLES Tracey Johnson Infection Control Specialist Nurse Overview Measles is a highly infectious viral illness. Measles virus is contained in the millions of tiny droplets produced when an infected person
More informationEtiology. only one antigenic type. humans are its only known reservoir
Rubella( German meas sles ) Etiology Togaviridae family --- genus Rubivirus single-stranded RNA enveloped virus, Its core protein is surrounded by a single-layer lipoprotein envelope with spike-like projections
More informationKhaled Ali Abu Ali. BSN. MPH. Ph.D. cand. -Nursing. Director of Epidemiology Department UCAS Lecturer
Khaled Ali Abu Ali BSN. MPH. Ph.D. cand. Director of Epidemiology Department UCAS Lecturer -Nursing Khaled_abuali@yahoo.com Communicable Disease Surveillance during Gaza War, 214. Introduction Public Health
More informationMeasles (Rubeola) Biology of measles virus. April 20, 2017 Department of Public Health Sciences
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 25 Measles Learning Objectives 1. Explain the disease burden of measles and why it still occurs 2. Identify the biologic characteristics
More informationWhich Diseases Should My Child Be Protected Against?
What is Immunization? Immunization is a process that helps your body fight off diseases caused by certain viruses and bacteria. One way for you to be immunized is to receive a vaccine. What is a Vaccine?
More informationOrthomyxoviridae and Paramyxoviridae. Lecture in Microbiology for medical and dental medical students
Orthomyxoviridae and Paramyxoviridae Lecture in Microbiology for medical and dental medical students Orthomyxoviridae and Paramyxoviridae are ss RNA containng viruses Insert Table 25.1 RNA viruses 2 SIZE
More informationObjectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015
Childhood Immunization Risk of Non-Vaccinated Children Bertha P. Rojas, Pharm.D. PGY-1 Pharmacy Resident South Miami Hospital Objectives Understand the definition of herd immunity Identify vaccine-preventable
More informationSpots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox
Chickenpox Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox Noelle Bessette, MPH Surveillance Specialist New Jersey Department of Health Vaccine Preventable Disease Program Caused
More information13 Mumps. Key information. Immunisation Handbook 2017 (2 nd edn, March 2018) 367
13 Mumps Key information Mode of transmission Incubation period Period of communicability Funded vaccine Dose, presentation, route Funded vaccine indications and schedule Vaccine efficacy/ effectiveness
More informationSpots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox
Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox Noelle Bessette, MPH Surveillance Specialist New Jersey Department of Health Vaccine Preventable Disease Program Chickenpox Caused
More informationNew Jersey Dept. of Health and Senior Services Vaccine Preventable Disease Program Measles Public FAQs. Date: June 8, 2011
New Jersey Dept. of Health and Senior Services Vaccine Preventable Disease Program Measles Public FAQs Date: June 8, 2011 Q: What is measles? DESCRIPTION OF MEASLES A: Measles is a very contagious respiratory
More informationDiseases of Absence. Disclosures
Diseases of Absence Meg Fisher, MD Medical Director, The Unterberg Children s Hospital Long Branch, NJ Disclosures I have no disclosures I do not intend to mention off label uses of drugs I have way too
More informationICM VI-09 DEFINITION REFERENCES
TITLE/DESCRIPTION: MANAGEMENT OF SELECTED AIRBORNE AND DROPLET INFECTIOUS DISEASE EXPOSURES IN HEALTHCARE WORKERS INDEX NUMBER: EFFECTIVE DATE: APPLIES TO: ISSUING AUTHORITY: 01/01/2009 01/01/2013 All
More informationAre you protected against measles mumps and rubella?
Are you protected against measles mumps and rubella? You re not if you haven t had MMR vaccine This leaflet tells you about measles, mumps and rubella and the MMR vaccination which helps protect against
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationF.A.S.N. annual conference 2009 Alix Casler, M.D., F.A.A.P. Orlando, FL
F.A.S.N. annual conference 2009 Alix Casler, M.D., F.A.A.P. Orlando, FL Immunization Update for School Nurses Overview of Vaccine Preventable Diseases FL Vaccine Requirements Medical Guidelines vs State
More informationMODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE
MODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE DESCRIPTION The vaccine is a freeze-dried powder containing three viruses - measles, mumps and rubella. a) The measles vaccine component is
More informationMICHAEL PARK A RUDOLF STEINER SCHOOL
MICHAEL PARK A RUDOLF STEINER SCHOOL 9 November 2011 Dear Parents/Caregivers, Re: English Measles To help contain an outbreak of English measles at Michael Park School, please contact me on 525 8995 or
More informationPart 1: Vaccine-Preventable Diseases and Childhood Vaccines
Part One Vaccine-Preventable Diseases and Childhood Vaccines Part 1: Vaccine-Preventable Diseases and Childhood Vaccines Diseases Here are the 14 diseases that can be prevented with routine childhood vaccination,
More informationPertussis immunisation for pregnant women
Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis. Before the introduction
More informationObjectives. Immunity. Diphtheria. Immunization Update July 22, Individual Immunity
Immunization Update July 22, 2008 Presented by Robert Brayden, MD Associate Professor, UCHSC Child Health Clinic, The Children s s Hospital Hosted by: Community Health Association of Mountain/Plains States
More informationViral Infections of the Respiratory System. Dr. MONA BADR Assistant Professor College of Medicine & KKUH
Viral Infections of the Respiratory System Dr. MONA BADR Assistant Professor College of Medicine & KKUH Objectives Introduction to respiratory viral infections Characteristics of respiratory viruses (Orthomyxoviridae,
More informationVaccine Preventable Diseases and healthcare workers
Vaccine Preventable Diseases and healthcare workers Expected learning outcomes At the end of this activity, you will: understand your responsibility to manage increased risks associated with vaccine preventable
More informationPolio Vaccine. By: Lia Schmitz, Pharm.D. Poliomylitis is a viral infection for which vaccination is generally given
Polio Vaccine By: Lia Schmitz, Pharm.D. Poliomylitis is a viral infection for which vaccination is generally given to infants and small children, and to people planning to travel to countries in which
More informationHEALTH ADVISORY: MEASLES EXPOSURES IN NEW YORK STATE
December 11, 2018 To: Health Care Providers, Hospitals, Emergency Departments, Dental Providers, and Local Health Departments From: New York State Department of Health, Bureau of Immunization HEALTH ADVISORY:
More informationImmunizations Offered
Immunizations Offered Most vaccines commercially available in the United States are available at the health clinic. A partial list of available vaccines follows. For more information about specific vaccines
More information2. How might a person find more information about a vaccine? 3. Why should some people not get the MMR vaccine?
Vaccines & Herd Immunity Text adapted from http://www.vaccines.gov/basics/index.html and http://www.pbs.org/wgbh/nova/body/herd-immunity.html [Retrieved Feb 2015] PART A: INDEPENDENT READING. On your own,
More informationfor Pharmacists and Pharmacy Technicians
Chapter 7: A Review of Measles, Mumps, and Rubella for Pharmacists and Pharmacy Technicians By: Katie Ingersoll, RPh, PharmD, and Staff Pharmacist for national chain. 4 Contact Hours Author Disclosure:
More informationVaccine Preventable Diseases in San Francisco. Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010
Vaccine Preventable Diseases in San Francisco Susan Fernyak, MD MPH CDCP Section Director and Deputy Health Officer August 17, 2010 Section Responsibilities Communicable Disease Control Unit (CDCU): Communicable
More informationVACCINE PREVENTABLE DISEASE EPIDEMIOLOGY
VACCINE PREVENTABLE DISEASE EPIDEMIOLOGY The Twenty-Second Annual Massachusetts Immunization Action Partnership Pediatric Immunization Skills Building Conference October 12, 2017 Marija PopStefanija, MPH,
More informationAPEC Guidelines Immunizations
Pregnancy provides an excellent opportunity to enhance a woman s protection against disease and to provide protection to the neonate during the first 3 to 6 months of life. Women of childbearing age should
More informationNYS Trends in Vaccine Preventable Disease Control
NYS Trends in Vaccine Preventable Disease Control Cindy Schulte, BSN, RN Bureau of Immunization 518-473-4437 crs01@health.state.ny.us 1 Objectives Participants will be able to identify disease outbreaks
More information46825 (260) $UPONT
Be wise. Immunize. Keeping track of the shots your children receive can be confusing. This is an important responsibility that is shared by you and your immunization providers. This booklet contains the
More informationIt IS a Small World After All: The Public Health Impact and Immunologic Assessment of a Disneyland Measles Case in El Paso County, Colorado
It IS a Small World After All: The Public Health Impact and Immunologic Assessment of a Disneyland Measles Case in El Paso County, Colorado Panel: Robyn Espy, M.P.H, Marigny Klaber, M.Sc., Shannon Rowe,
More informationWho makes these rules? 04/19/2013. Guidelines for vaccine schedules Vaccine information materials Worksheets for assessing immunization i records
2013 Childcare Provider Immunization Training Please sign in, take a packet and pretest Objectives Know immunization exemptions allowed in Nevada Identify immunizations required and recommended for childcare
More informationCHILDHOOD IMMUNIZATIONS. 10 December 2009 Heather Schembari
CHILDHOOD IMMUNIZATIONS 10 December 2009 Heather Schembari Immunity Passive- Immunoglobulins are transported from mother to baby across the placenta. IgA is acquired through breast milk. Baby inherits
More information11/19/2018 MUMPS SYRACUSE UNIVERSITY Background
MUMPS SYRACUSE UNIVERSITY 2017-2018 Background VIRAL ILLNESS CAUSED BY A PARAMYXOVIRUS HUMANS ONLY RESERVOIR AVERAGE INCUBATION FROM EXPOSURE TO SYMPTOMS STARTING IS 16-18 DAYS WIDESPREAD VACCINATION IN
More informationMyelitis= inflammation of the spinal cord
Polio infection 1 Illustrate the epidemiology of the disease 2 Demonstrate the clinical features of polio infection 3 Enumerate the complications 4 Prevent and treat polio infection MUMPS 1 Identify the
More informationM-M-R II Merck Sharp & Dhome
M-M-R II Merck Sharp & Dhome measles, mumps, and rubella virus vaccine live Composition (measles, mumps, and rubella virus vaccine live) is a live virus vaccine for immunization against measles (rubeola),
More informationVaricella (Chickenpox) and Varicella Vaccines
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Varicella (Chickenpox) and Varicella Vaccines September 2018 Photographs and images included in this
More informationPolio (Paralytic and Non-paralytic
Polio (Paralytic and Non-paralytic Infection) rev Jan 2018 Infectious Agent Poliovirus (genus Enterovirus) types, 1, 2, and 3. BASIC EPIDEMIOLOGY Transmission Poliovirus is transmitted by person-to-person
More informationCommunity Immunization Education Guide Tool Kit
Community Immunization Education Guide Tool Kit Contents Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Purpose How to Use the Five Key Messages Pre-Training Survey Overview Vaccine Preventable
More information18 Rubella. Key information. Immunisation Handbook 2017 (2 nd edn, March 2018) 485
18 Rubella Key information Mode of transmission Incubation period Period of communicability Funded vaccine Dose, presentation, route Funded vaccine indications and schedule Pregnancy Vaccine efficacy/
More informationBROUGHT TO YOU BY. Immunizations
BROUGHT TO YOU BY Immunizations The Centers for Disease Control and Prevention (CDC) recommends vaccinations throughout your life to protect against many infections. When you skip vaccines, you leave yourself
More informationThe Continued Need for Immunizations in Top Ten Causes of Death in the U.S., 1900 vs Common Questions about Vaccines
The Continued Need for Immunizations in 2016 Stephanie Schauer, Ph.D. Program Manager, Immunization Program April 13, 2016 Ten Great Public Health Achievements United States, 1900-1999 MMWR 1999 Control
More informationThe Continued Need for Immunizations in 2016
The Continued Need for Immunizations in 2016 Stephanie Schauer, Ph.D. Program Manager, Immunization Program April 13, 2016 Wisconsin Department of Health Services Ten Great Public Health Achievements United
More informationIMMUNIZATION PROTOCOLS FOR PHARMACISTS. VARICELLA Live Virus Vaccine
IMMUNIZATION PROTOCOLS FOR PHARMACISTS VARICELLA Live Virus Vaccine I. ORDER: 1. Screen for contraindications and evidence of immunity (Section VII.K.) 2. Provide a current Vaccine Information Statement
More information301 W. Alder, Missoula, MT or
301 W. Alder, Missoula, MT 59802 406-258-4745 or 406-258-3363 Routine Immunizations are available on a walk-in basis: Mondays, Tuesdays, Thursdays, and Fridays from 9:00am to 4:30pm Wednesdays, 10:00am-4:30pm
More informationLet s talk about protection Childhood Vaccination. Flipbook to support conversations with parents and caregivers
Let s talk about protection Childhood Vaccination Flipbook to support conversations with parents and caregivers F Let s talk about protection Childhood Vaccination Flipbook to support conversations with
More informationTo provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV).
Effective Date: 04/18 Replaces: 0 4 / 1 3 / 1 7 Page 1 of 4 POLICY: To provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV). DEFINITIONS Two syndromes occur from
More informationBacterial Vaccines I 5/28/04 LECTURE OUTLINE I. CASE HISTORY
5/28/04 Bacterial Vaccines I LECTURE OUTLINE I. CASE HISTORY A man runs across a football field, feels something jab him in the foot and falls down. He plucks a rusty nail out of his foot and forgets about
More informationPregnant? There are many ways to help protect you and your baby. Immunise against: Flu (Influenza) Whooping cough (Pertussis) German measles (Rubella)
Pregnant? There are many ways to help protect you and your baby Immunise against: Flu (Influenza) Whooping cough (Pertussis) German measles (Rubella) mmunisation This leaflet describes the vaccinations
More informationMeasles. Chapter 12 Measles. Measles. Measles vaccine introduced in 1985/ MMR introduced in 1988 NOTIFIABLE
Chapter 12 12 vaccine introduced in 1985/ MMR introduced in 1988 NOTIFIABLE In some circumstances, advice in these guidelines may differ from that in the Summary of Product Characteristics of the vaccines.
More informationOverview. Symptoms Treatment Prevention Surveillance Mumps in the News Role of the ICP
Mumps Overview Definition Etiology Pathogenesis Symptoms How is it spread? Risks Symptoms Treatment Prevention Surveillance Mumps in the News Role of the ICP Mumps What it is Mumps or epidemic parotitis,
More informationHealth Care Workers (HCWs) in Ireland should have 2 doses of MMR vaccine. Two of the cases in recent outbreaks in Ireland were HCWs.
This information should be read in conjunction with Immunisation Guidelines for Ireland available at http://bit.ly/niacguidelines Summary of Product Characteristics for MMR vaccines available at www.hpra.ie
More informationCHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
More informationMID 33. Gastrointestinal Viruses. Gastrointestinal Viruses: Rotavirus and the Enteroviruses. Childhood diarrheal disease
Gastrointestinal Viruses Gastrointestinal Viruses: Rotavirus and the Enteroviruses Viral diarrheal illness o tremendous cause of morbidity/mortality worldwide o rotavirus, calicivirus (norovirus), astrovirus,
More informationYour guide to understanding childhood immunisation
Your guide to understanding childhood immunisation Your guide to understanding childhood immunisation ISBN: 978-1-74186-077-1 Publications approval number: 10549 Commonwealth of Australia 2013 This work
More informationBreaking the Chain of Infection DOM Education Day October 27, 2014 Jodi-Marie Black RN BScN PHN
Breaking the Chain of Infection DOM Education Day October 27, 2014 Jodi-Marie Black RN BScN PHN Topics Covered in Presentation The Chain of infection and how to break the chain Role of the Designated Officer
More informationMumps in the Community Dr. Isabel Oliver, A Webber Training Teleclass
Overview MUMPS in the Community Dr. Isabel Oliver Consultant Regional Epidemiologist HPA South West Isabel.oliver@hpa.org.uk www.webbertraining.com The Health Protection Agency Mumps Control of mumps Epidemiology
More informationPHARMACEUTICAL MICROBIOLOGY. Dr. Müjde ERYILMAZ
PHARMACEUTICAL MICROBIOLOGY Dr. Müjde ERYILMAZ Virology OBJECTIVES Enveloped RNA Viruses Influenza Virus Measles (Rubeola) Rubella (German Measles, Three-Day Measles) Mumps Human Parainfluenza Viruses
More informationBlood Borne Pathogens. November 2010
Blood Borne Pathogens November 2010 Objectives Meet requirements of OSHA Standard 29 CFR 1910.1030 OSHA Blood Borne Pathogens Post Test Routes of Transmission Types of Pathogens BSI / PPE Common Diseases
More informationVaccines for Children
Vaccines for Children 12 24 old Our goal is to offer your family the best care possible, which includes making sure your child is up to date on all vaccines. DTaP (Diptheria, Tetanus, Pertussis) Vaccine
More informationFrequently asked questions (FAQs) on MR vaccination campaign
Frequently asked questions (FAQs) on MR vaccination campaign What are measles/rubella diseases? Measles is a highly infectious disease causing illness and death due to complications in the form of diarrhea,
More informationBCCDC Measles, Mumps and Rubella Enhanced Surveillance Case Report Form
A. PERSON REPTING Disease: Measles Mumps Rubella INSTRUCTIONS Report cases of Measles, Mumps and/or Rubella to your MHO that meet suspect, probable/clinical or confirmed case definitions. Enter cases into
More information2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
More informationMumps. Ellen Dorshow-Gordon, MPH Jackson County Health Department March Follow Us on Social Media:
Mumps Ellen Dorshow-Gordon, MPH Jackson County Health Department March 2017 1 Epidemiology Mumps is a mild acute viral illness, often asymptomatic Etiologic agent is paramyxovirus, a member of the Rubulavirus
More informationFrequently asked questions (FAQs) on MR vaccination campaign. Training Workshop for Measles-Rubella Vaccination Campaigns
Frequently asked questions (FAQs) on MR vaccination campaign Training Workshop for Measles-Rubella Vaccination Campaigns What are measles/rubella diseases? Measles is a highly infectious disease causing
More informationVaccines. Bacteria and Viruses:
1 Immunity Resistance to or protection against a specific disease; {power to resist infection. Every day, bacteria, viruses and other germs attack our bodies. But we usually don t get sick. That s because
More informationRoutine Office Visits
Routine Office Visits Routine office visits are scheduled in advance. Since the office computer allows us to book appointments months in advance, you will often be able to make your next appointment as
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationMeasles Redux FEBRUARY 26, Karen Holbrook, MD MPH Deputy Health Officer
Measles Redux FEBRUARY 26, 2015 Karen Holbrook, MD MPH Deputy Health Officer What is Measles? Severe Viral Infection: Rubeola ~ 1 in 4 hospitalized ~ 1 in 20 pneumonia ~ 1 in 1,000 encephalitis ~ 1 or
More informationEmerging Pathogens and Outbreaks
Emerging Pathogens and Outbreaks Derek Forster, MD Assistant Professor of Medicine, Division of Infectious Diseases Medical Director, Infection Prevention and Control UK HealthCare Objectives Review emerging
More informationIntroduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa
Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Nigeria Center for Disease Control Federal Ministry of Health Abuja July 2015 Outline 1. Measles disease 2. Progress towards
More informationPolio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010
Polio vaccines and polio immunization in the pre-eradication era: WHO position paper Published in WER 4 June, 2010 Epidemiology & Background Poliomyelitis (polio) is an acute communicable disease of humans
More informationprotect your child IMMUNIZE ON TIME, EVERY TIME. Haemophilus Influenzae Type B (Hib) Human Papillomavirus (HPV) Influenza (Flu) Disease Disease
protect your child IMMUNIZE ON TIME, EVERY TIME. Diphtheria Haemophilus Influenzae Type B (Hib) Hepatitis A Hepatitis B Human Papillomavirus Influenza (Flu) Measles Meningococcal Disease Mumps Pertussis
More information